Tiafibrate is a fibrate-class medication primarily indicated for the treatment of hypertriglyceridemia and mixed dyslipidemia. By acting as a peroxisome proliferator-activated receptor-alpha (PPAR-alpha)… Read more
Tiafibrate is a fibrate-class medication primarily indicated for the treatment of hypertriglyceridemia and mixed dyslipidemia. By acting as a peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, this therapeutic agent effectively lowers blood triglyceride levels, increases lipoprotein lipase activity, and reduces VLDL production. To support rigorous pharmaceutical analysis, this category offers a comprehensive selection of Tiafibrate reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These high-quality reference materials are essential for accurate impurity profiling, method development, and validation in pharmaceutical quality control laboratories. Utilizing characterized stable isotope-labelled standards and impurity markers allows researchers to ensure precise quantification and regulatory compliance throughout the lifecycle of drug manufacturing and stability testing, providing the consistency required for reliable analytical outcomes in the pharmaceutical industry.